News

February 24, 2017

Current, Former Female Inmates Far More Likely to Develop Cervical, Lung Cancer, Study Finds

News

Women who have done time in prison are three times more likely to die from cervical cancer than women who were never behind bars, according to a Canadian study. That’s one of ... Read more

February 22, 2017

New Model for Cervical Cancer Care in Botswana Cuts Treatment Delays by More Than Half

News

Multidisciplinary team clinics in low- and middle-income countries are realistic and can help reduce delays in cervical cancer treatment, as demonstrated by a new model of cervical cancer care implemented in Botswana. ... Read more

February 21, 2017

Lesbians Less Likely to Be Screened for Cervical Cancer than Other Women

News

Lesbians are less likely to get timely cervical cancer screening than heterosexual and bisexual women, concludes a study by Rice University. The study, “Cancer Screening Utilization Among U.S. Women: How Mammogram ... Read more

February 17, 2017February 17, 2017

Number of Lymph Nodes Carrying Tumor Cells May Help to Predict Survival in Cervical Cancer

News

Researchers found that measuring the number of lymph nodes (LNs), nodules of white blood cells, that carry cervical cancer cells (positive LNs) helps to the predict survival time of patients ... Read more

February 15, 2017April 24, 2017

Inovio, ApolloBio to Jointly Develop HPV Vaccine in China, Taiwan

News

ApolloBio now enjoys exclusive rights to market Inovio Pharmaceuticals‘ DNA immunotherapy product, VGX-3100, in China and Taiwan under a new collaboration and licensing agreement. The deal allows ApolloBio to develop VGX-3100 as a non-surgical treatment ... Read more

February 13, 2017

HPV Vaccination in 2-Dose Schedule Endorsed by American Cancer Society

News

In October 2016, the U.S. Food and Drug Administration (FDA) approved the two-dose schedule for the human papillomavirus (HPV) vaccine, which was later recommended for boys and girls ages 9 ... Read more

February 10, 2017

New Technique Curbs Cervical Cancer Cell Migration, Study Says

News

Certain regions in the cell’s membrane, called lipid rafts, could be used to halt the migration and survival of cervical cancer cells, according to results of a new study. The findings may ... Read more

February 8, 2017

First Doses of AXAL Administered to Phase 3 Cervical Cancer Trial Participants

News

The first doses of Advaxis‘ axalimogene filolisbac, or AXAL, have been administered to women with advanced cervical cancer in a Phase 3 trial of the treatment’s effectiveness after chemotherapy and radiation. The multicenter, ... Read more

February 6, 2017February 13, 2017

FDA OKs Elekta’s Venezia Brachytherapy Applicator for Cervical Cancer Treatment

News

U.S. regulators have approved the Venezia applicator for treating advanced-stage cervical cancer, according to the device’s maker, Elekta. The Food and Drug Administration‘s (FDA’s) 510(k) clearance means the applicator can be marketed in the United States. The ... Read more

February 3, 2017

Cancer Risk Higher for Those Who Don’t Follow-Up on Cervical Abnormalities

News

Women with moderate-to-severe changes in their cervical cells who don’t get follow-up testing or treatment are four times more likely to develop cervical cancer than women who receive treatment, according ... Read more